Recuro Health raises $47 million to expand virtual care

Recuro, an integrated digital health solutions company, has announced the closing of a $47 million Series B funding round. Investors included ARCH Venture Partners, the Flippen Group, GPG Ventures, and 4D Capital, among others. 

Recuro Health will use the funding to scale its Digital Medical Home, which offers patients virtual access to healthcare services, such as behavioural health, virtual primary and urgent care genomic testing, and at-home lab testing.

The funding follows a Series A funding round in 2021, in which the company raised $15 million. Recuro Health has also completed a series of acquisitions, purchasing MyLifeIQ and SupDoc in 2021. Last year, Recuro acquired virtual healthcare providers WellVia and announced the acquisition of digital health company Competitive Health. 

“The continued support of our investors is a clear sign of their confidence in our mission,” says Michael Gorton, CEO and founder, Recuro Health. “We have an extraordinary team at Recuro dedicated to evolving healthcare to be more proactive and personal, resulting in improved outcomes, better patient engagement and lower costs. In this next phase of our Company growth and expansion, we are committed to building upon the success of our Digital Medical Home and continuing to advance the next generation of digital care services."

Recuro’s digital health solutions are available across the U.S and currently used by millions of members. 

Click here to read the original news story